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Edited by Gianni CesareniAbstract Paraﬁbromin is a putative tumor suppressor encoded
by HRPT2 and implicated in parathyroid tumorigenesis. We
previously reported a functional bipartite nuclear localization
signal (NLS) at residues 125–139. We now demonstrate that
paraﬁbromin exhibits nucleolar localization, mediated by three
nucleolar localization signals (NoLS) at resides 76–92, 192–
194 and 393–409. These NoLS represent clusters of basic amino
acids arginine and lysine, similar to those found in other nucleo-
lar proteins, as well as being characteristic of NLSs. While para-
ﬁbromin’s bipartite NLS is the primary determinant of nuclear
localization, it does not mediate nucleolar localization. In con-
trast, the three identiﬁed NoLSs play only a minor role in nucle-
ar localization, but are critical for the nucleolar localization of
paraﬁbromin.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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localization signal; Parathyroid1. Introduction
Paraﬁbromin is a ubiquitously expressed 531 amino acid
protein with a C-terminus showing homology to the yeast pro-
tein Cdc73. Cdc73 is a member of the Paf1 complex, composed
of Paf1, Cdc73, Ctr9, Leo1 and Rtf1. This complex binds to
RNA polymerase II and is implicated in a number of transcrip-
tion related events. A human counterpart to the yeast Paf1
complex has been identiﬁed and is composed of hLeo1, hPaf1,
hCtr9, paraﬁbromin and hSki8 (reviewed in [1]).
Predicted loss of function mutations in the gene encoding
paraﬁbromin, HRPT2, are present in patients with the familial
parathyroid cancer syndrome Hyperparathyroidism Jaw
Tumor syndrome, as well as in sporadic parathyroid cancer
[2–4]. Further, loss of paraﬁbromin immunoreactivity has been
reported in parathyroid tumors harboring HRPT2 mutations
[5,6]. Overexpression of paraﬁbromin inhibits cell proliferation
and colony formation [7], as well as induces apoptosis [8] and
G1 phase cell cycle arrest [7]. Taken together, these ﬁndings
support a tumor suppressor function for HRPT2/paraﬁbromin
in parathyroid tumorigenesis.
We have previously reported a functional bipartite nuclear
localization signal (NLS) within paraﬁbromin at residues
125–139 [9]. We now demonstrate that paraﬁbromin is also*Corresponding author. Fax: +61 2 9926 8484.
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doi:10.1016/j.febslet.2007.09.050localized to the nucleolus and that three nucleolar localization
signals (NoLSs) at residues 76–92, 192–194 and 393–409 play
only a minor role in nuclear localization but are critical for
the nucleolar localization of this protein.2. Materials and methods
2.1. Cloning and site directed mutagenesis
Sense and antisense oligonucleotides encoding each NoLS were
generated (Sigma–Aldrich), annealed and cloned into pEGFP-C1
(Clontech). Nucleolin was PCR ampliﬁed using AccuPrime Pfx (Invit-
rogen) from HEK293 cDNA and cloned into pDsRed-C1 (Clontech).
Site directed mutagenesis was carried out on pEGFP-C1-HRPT2 [9] to
convert basic amino acids within each signal to neutral amino acids
using the QuickChange II site directed mutagenesis kit (Stratagene).
Constructs were veriﬁed by sequencing (Supamac, Sydney University,
NSW, Australia). Sequences of oligonucleotides and mutagenesis
primers are available upon request.
2.2. Cell culture, transfections and western blot
Human embryonic kidney (HEK293) cells were cultured, transfected
and extracts western blotted using an anti-GFP or anti-DsRed anti-
body (Clontech) as previously described [9].
2.3. Immunoﬂuorescent microscopy
Forty-eight hours post transfection cells were stained with Hoechst
33258 and visualized as previously described [9]. For experiments exam-
ining nuclear only EGFP localization (conﬁrmed using Hoechst stained
nuclei), a minimum of 200 transfected cells from four diﬀerent ﬁelds were
counted.For experiments inwhich the percentage of cells exhibiting cyto-
plasmic > nuclear EGFP ﬂuorescence/unit area was determined a mini-
mum of 100 cells from two photomicrographs were analyzed using
Multi Gauge software (FUJIFILM). Fluorescence intensity was mea-
sured and compared in unit areas of constant size chosen arbitrarily in
both the nucleus and cytoplasm (conﬁrmed usingHoechst stained nuclei)
and the percentage of transfected cells exhibiting cytoplasmic > nuclear
EGFP ﬂuorescence intensity/unit area was determined. For determina-
tions of the percentage of cells exhibiting nucleolar localization or exclu-
sion at least 200 cells from four diﬀerent ﬁelds in each of three separate
experiments were assessed and the percentage of cells showing nucleolar
localization determined. All EGFP constructs used were co-localized
with nucleolin fused to DsRed to conﬁrm nucleolar localization.
2.4. Statistical analysis
Diﬀerences between groups within experiments were examined by
ANOVA followed by post hoc analysis using Fisher’s protected least
signiﬁcant diﬀerence test.3. Results
3.1. Paraﬁbromin fused to EGFP is localized to the nucleolus
Paraﬁbromin-EGFP expressed in HEK293 cells was pre-
dominantly nuclear, evenly distributed, not excluded fromblished by Elsevier B.V. All rights reserved.
Fig. 1. Paraﬁbromin-EGFP is localized to the nucleolus of HEK293 cells (A). Western blot analysis of HEK293 cells transiently transfected with
pEGFP-C1 (lane 1), pEGFP-C1-HRPT2 (lane 2), pDsRed-C1 (lane 3) or pDsRed-Nucleolin (lane 4) (B). Co-localization of paraﬁbromin-EGFP and
nucleolin-DsRed to the nucleolus of HEK293 cells.
Fig. 2. Three putative NoLSs fused to EGFP mediate nuclear and
nucleolar localization. (A) Mean percentage (±SEM) of transfected
cells exhibiting nuclear only EGFP. ** P < 0.001, signiﬁcantly larger
values than those obtained from cell populations transfected with
EGFP or NoLS 1, NoLS 2 or NoLS 3 fused to EGFP. * P < 0.01,
signiﬁcantly larger values than those obtained from cell populations
transfected with NoLS 2-EGFP. (B) Mean percentage (±SEM) of
transfected cells exhibiting nucleolar EGFP.
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sub-nuclear localization was observed. The nucleolar marker
nucleolin [10] was fused to DsRed and along with paraﬁbro-
min-EGFP expressed in HEK293 cells. Western blot analysis
using anti-GFP or anti-DsRed antibody conﬁrmed the expres-
sion of fusion proteins of the predicted molecular weight
(87 kDa-paraﬁbromin-EGFP, 132 kDa-nucleolin-DsRed)
(Fig. 1A). In cells expressing both tagged proteins, co-localiza-
tion was observed, conﬁrming the nucleolar localization of
paraﬁbromin-EGFP (Fig. 1B).
3.2. Paraﬁbromin contains three putative NoLSs
Since NLS as well as NoLS are sequences rich in the basic
amino acids arginine and lysine we investigated four of these
signals for their ability to mediate nuclear and nucleolar para-
ﬁbromin by fusing each signal to EGFP; residues 125–139 [9]
(NLS), two other signals described as putative NLS [6,8,11]
(NoLS 1, residues 76–92 and NoLS 3, residues 393–409),
and a small cluster of basic amino acids at residues 192–194
(NoLS 2). Western blot analysis using an anti-GFP antibody
of HEK293 cells transfected with each construct revealed
expression of fusion proteins of the predicted molecular weight
(data not shown). Cells transfected with each signal fused to
EGFP revealed increased nuclear localization of each of the fu-
sion proteins compared to EGFP alone. The percentage of
transfected cells exhibiting nuclear only EGFP localization
was determined in these experiments and used as a measure
of the nuclear import capability of each signal (Fig. 2A). The
bipartite NLS exhibited signiﬁcantly (P < 0.001) higher nucle-
ar import activity than NoLS 1, 2 and 3. NoLS 1 and 3 also
possessed signiﬁcantly (P < 0.01) higher import activity than
NoLS 2.
Sub-nuclear localization similar to that observed for paraﬁ-
bromin-EGFP was also observed in cells expressing NoLS 1, 2
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with nucleolin-DsRed conﬁrmed sub-nuclear localization as
nucleolar. Quantitation of sub-nuclear ﬂuorescence revealed
nucleolar localization in approximately 10% of cells expressing
NoLS 1 or 3-EGFP, 40% of cells expressing NoLS 2-EGFP
and was not observed in cells expressing the bipartite NLS-
EGFP or EGFP alone (Fig. 2B).
3.3. Three putative NoLS exhibit both nuclear import and
nucleolar localization activity in full length paraﬁbromin
fused to EGFP
To investigate the nuclear import and nucleolar localization
activity of NoLS 1, 2 and 3 each signal was mutated alone or
together in full length HRPT2 fused to EGFP (Fig. 3A). TheseFig. 3. NoLS 1, 2 and 3 exhibit nuclear import activity in full length
paraﬁbromin. (A) Basic amino acids within the bipartite NLS or NoLS
1, 2 or 3 were mutated to neutral amino acids as shown. (B) The mean
percentage (±SEM obtained from three separate experiments) of
transfected cells exhibiting nuclear only EGFP. Signiﬁcantly lower
values than those obtained from cell populations transfected with wild
type paraﬁbromin-EGFP were obtained in all cases except for NoLS 2.
*P < 0.05, **P < 0.01, ***P < 0.001. (C) The mean percentage (± SEM)
of transfected cells exhibiting cytoplasmic > nuclear EGFP ﬂuores-
cence intensity/unit area. * P < 0.01, signiﬁcantly higher values than
those obtained from cell populations transfected withHRPT2 in which
the bipartite NLS was mutated fused to EGFP.constructs, as well as wild-type and HRPT2 in which four
amino acids of the bipartite NLS were mutated to neutral ami-
no acids fused to EGFP (Fig. 3A), were transfected into
HEK293 cells. Western blot showed that the fusion protein ex-
pressed from each mutant construct was the same molecular
weight as wild-type paraﬁbromin fused to EGFP (data not
shown). Quantitation of the percentage of cells exhibiting nu-
clear only EGFP localization demonstrated that mutation of
NoLS 1 or 3 individually or NoLS 1, 2 and 3 together signif-
icantly reduced nuclear localization of paraﬁbromin-EGFP
(NoLS 1 alone or NoLS 1, 2 and 3 together; P < 0.01. NoLS
3 alone; P < 0.05). Mutation of NoLS 2 alone did not signiﬁ-
cantly reduce nuclear localization. In contrast, mutation of the
bipartite NLS completely abolished (P < 0.001) nuclear only
localization of paraﬁbromin-EGFP, resulting in expression
of this fusion protein in both nuclear and cytoplasmic com-
partments (Fig. 3B). This suggests that the bipartite NLS is
the primary determinant of paraﬁbromin nuclear localization.Fig. 4. NoLS 1, 2 and 3 mediate nucleolar localization of full length
paraﬁbromin-EGFP. (A) The mean percentage (±SEM) of transfected
cells exhibiting nucleolar EGFP. * P < 0.001, signiﬁcantly lower values
than those obtained from cell populations transfected with wild-type
HRPT2 fused to EGFP. (B) Co-expression of paraﬁbromin-EGFP in
which NoLS 1, 2 and 3 had been mutated and nucleolin-DsRed. (C)
The mean percentage (±SEM) of transfected cells exhibiting EGFP
nucleolar exclusion. ** P < 0.001, signiﬁcantly higher values than those
obtained from cell populations transfected with HRPT2 in which
NoLS 1 was mutated fused to EGFP. * P < 0.01, signiﬁcantly higher
values than those obtained from cell populations transfected with wild-
type HRPT2 fused to EGFP.
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ar import of paraﬁbromin its function needed to be abrogated
in order to properly assess the nuclear import activity of NoLS
1, 2 and 3. The bipartite NLS and either NoLS 1, 2 or 3 were
mutated in full length paraﬁbromin fused to EGFP. Since nu-
clear only localization was not observed in cells transfected
with these constructs, EGFP localization was quantitated by
determining the percentage of cells in which cytoplasmic was
greater than nuclear EGFP ﬂuorescence intensity/unit area.
An increase in the number of cells in which cytoplasmic was
greater than nuclear EGFP ﬂuorescence intensity/unit area
was taken to be indicative of a decrease in nuclear localization.
Mutation of NoLS 1, 2 or 3 in addition to the bipartite NLS
signiﬁcantly (P < 0.01) increased the percentage of cells in
which cytoplasmic was greater than nuclear EGFP intensity/
unit area, therefore decreasing nuclear localization when com-
pared to mutation of the bipartite NLS alone (Fig. 3C).
Quantitation of the nucleolar localization in HEK293 cells
transfected with HRPT2-EGFP in which NoLS 1, 2 or 3,
NoLS 1 and 3 or NoLS 1, 2 and 3 had been mutated showed
that mutation of NoLS 1, 2 and 3 abolished nucleolar localiza-
tion while mutation of NoLS 1 and 3 together or NoLS 1 and 3
alone signiﬁcantly (P < 0.001) reduced the percentage of cells
showing nucleolar localization compared to wild-type paraﬁ-
bromin. Mutation of NoLS 2 also signiﬁcantly (P < 0.001) re-
duced nucleolar localization but to a lesser extent than the
other constructs (Fig. 4A). It was noted that mutation of var-
ious NoLSs also induced nucleolar exclusion (Fig. 4B). Quan-
titation revealed a signiﬁcant (P < 0.01) increase in nucleolar
exclusion when NoLS 1 alone or in combination with NoLS
3 was mutated compared to wild-type. This was signiﬁcantly
larger (P < 0.001) when all three NoLSs were mutated in com-
bination. Mutation of NoLS 2 or 3 alone did not signiﬁcantly
increase nucleolar exclusion compared to wild-type (Fig. 4C).4. Discussion
In co-localization studies with the nucleolar marker nucleo-
lin we have shown that paraﬁbromin is a nucleolar protein.Fig. 5. Protein domains and region of homology identiﬁed within paraﬁbrom
[9,15,16].Using a number of EGFP fusion constructs we demonstrate
that nucleolar localization of paraﬁbromin is mediated by
three sequences rich in the basic amino acids arginine and ly-
sine at residues 76–92 (NoLS 1), 192–194 (NoLS 2) and 393–
409 (NoLS 3). Each NoLS can also mediate nuclear import
although to a much lesser degree than the bipartite NLS at res-
idues 125–139 which is the primary determinant of nuclear
localization of paraﬁbromin but is unable to mediate nucleolar
localization of this protein.
Since our original identiﬁcation of a bipartite NLS at
residues 125–139 other studies have investigated the nuclear
import capability of multiple putative NLS within paraﬁbro-
min. One report suggested that a monopartite NLS at residues
136–139 was the sole mediator of paraﬁbromin nuclear import
[11]. However, when this signal was mutated in paraﬁbromin-
EGFP, a fusion protein of approximately 90 kDa and there-
fore unable to passively diﬀuse across the nuclear pore com-
plex [12], complete nuclear exclusion was not observed
indicating the likely presence of additional sequences mediat-
ing nuclear import. In support of this and conﬁrming our ori-
ginal ﬁnding a more recent study has demonstrated that the
bipartite NLS at residues 125–139 described by us [9] and
not 136–139 alone is the primary determinant of paraﬁbromin
nuclear localization [8]. This report also found that mutation
of the bipartite NLS, in addition to the signal we describe as
NoLS 1, increased nuclear exclusion of paraﬁbromin-EGFP.
We have now extended this study to show that paraﬁbromin
contains four signals that when fused to EGFP alone or mu-
tated in full length paraﬁbromin diﬀerentially mediate nuclear
import.
In support of our ﬁnding that paraﬁbromin is a nucleolar
protein, a database of the nucleolar proteome that contains
information on over 700 proteins includes paraﬁbromin
(www.lamondlab.com/Nopdb) [13]. Other proteins such as
IGF-I, MDM2 and p14ARF [14] also contain NoLSs com-
posed of clusters of basic amino acids very similar to those that
have been identiﬁed in NLSs and in some cases overlap these
signals. Further, a number of these proteins such as p14ARF
also have multiple NoLSs required for nucleolar localization
[14].in. Previously reported regions are noted in the lower half of the ﬁgure
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quence have previously been identiﬁed in addition to the three
NoLSs from this study (Fig. 5) [9,15,16]. Although minimal
binding determinants within the b-catenin interaction domain
(CID) and the region required for binding of the rest of the
Paf1 complex have not been identiﬁed in paraﬁbromin, both
regions are close to or overlap with, NoLS 2 or 3. Binding
of either b-catenin or the rest of the Paf1 complex may inﬂu-
ence the cellular localization of paraﬁbromin. We have shown
that the three NoLSs together mediate nucleolar localization.
It is therefore tempting to speculate that these three signals
may be closely associated in the three-dimensional structure
of paraﬁbromin, together forming a protein or nucleic acid
binding domain important for function as has been shown
for lysine and arginine rich NoLS in other proteins [17].
Identiﬁcation of the signals that mediate the cellular locali-
zation of paraﬁbromin is crucial in furthering our understand-
ing of how this protein might function both normally and in
the context of tumorigenesis. Other tumor suppressors, includ-
ing Rb, p53 and p14ARF have been localized to the nucleolus
and shown to regulate rRNA synthesis and processing, cell
cycle progression and/or cell growth [18]. Future studies will
reveal whether the reported eﬀects of paraﬁbromin on cell cy-
cle progression and proliferation are mediated via its nucleolar
localization or whether the nucleolus represents a site of novel
paraﬁbromin function.
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